About
Cancer & Orphan Drugs
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
150
By Phase
EARLY_PHASE1: 1PHASE1/PHASE2: 1PHASE1: 1
By Status
WITHDRAWN: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT04294875Lead Sponsor
Phase I, FIH, MTD for MPT0B640, Multi-centre, Open-label, Subject With Locally Advanced or Metastatic Solid Malignancies
EARLY_PHASE1Withdrawn
Started: Dec 31, 2025 · Completed: Nov 30, 2027
NCT05394831Lead Sponsor
A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
PHASE1/PHASE2Recruiting
150 participants
Started: Jul 30, 2023 · Completed: Sep 30, 2026
NCT04526717Lead Sponsor
Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection
PHASE1Withdrawn
Started: Dec 31, 2021 · Completed: Dec 31, 2022
Locations (1)
Headquarters
Seoul, Korea
Map
Loading map...